Przejdź do zawartości
Merck

Przejdź do

16-662

Magna ChIP® Kulki magnetyczne z białkiem G

Recombinant Protein G covalently bound to magnetic beads for use in chromatin immunoprecipitations (ChIP assays). These protein G beads provide users a more rapid, reproducible & efficient reagent for collecting immunocomplexes vs. agarose beads.

Magna ChIP® Protein G Magnetic Beads

Synonim(y):

Immunoprecypitacja chromatyny magnetycznej, Kulki magnetyczne ChIP, kulki magnetyczne ChIP G

Zaloguj się, aby wyświetlić ceny organizacyjne i kontraktowe.

Wybierz wielkość

Zmień widok
Gabaryty przesyłkiSKUDostępnośćCena netto
50 reactions

Przewidywany termin wysyłki25 maja 2026zKuehne + Nagel Sp. z o.o.

1410,00 zł

Informacje o tej pozycji

UNSPSC Code:
41105507
NACRES:
NA.52
eCl@ss:
32160405

1410,00 zł


Przewidywany termin wysyłki25 maja 2026Szczegóły


Zamów zamówienie zbiorcze
Pomoc techniczna
Potrzebujesz pomocy? Nasz zespół doświadczonych naukowców chętnie Ci pomoże.
Pozwól nam pomóc


Quality Level

packaging

pkg of 1 mL

manufacturer/tradename

Magna ChIP®

particle size

~3 μm

shipped in

wet ice

storage temp.

2-8°C

General description

Recombinant protein G covalently bound to magnetic beads. These beads provide users a rapid, reproducible and efficient reagent for collecting immunocomplexes for chromatin immunoprecipitations (ChIP) assays. Compared with conventional protein G agarose beads, protein G magnetic beads significantly reduce the handling time and mechanical stress on target immunocomplexes.

Application

Recombinant Protein G covalently bound to magnetic beads for use in chromatin immunoprecipitations (ChIP assays). These protein G beads provide users a more rapid, reproducible & efficient reagent for collecting immunocomplexes vs. agarose beads.
Research Category
Epigenetics & Nuclear Function
Use 20 µL of bead suspension per ChIP application. Includes sufficient reagents for 50 precipitation reactions. Disperse beads thoroughly before pipetting by rapid vortex.
Used to detect/quantify: Protein G

Physical form

Liquid suspension. Supplied as magnetic bead slurry in phosphate buffered saline, pH 7.4, containing 0.01% Tween®-20 and 0.09% sodium azide.

Preparation Note

Stable for 1 year at 2-8°C from date of shipment. Do Not Freeze.

Analysis Note

Routinely evaluated by Chromatin immunoprecipitation (ChIP) using HeLa nuclear extracts and the Magna ChIP® A Kit (Cat. #17-610).

Legal Information

MAGNA CHIP is a registered trademark of Merck KGaA, Darmstadt, Germany
TWEEN is a registered trademark of Croda International PLC

Disclaimer

Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.
Ta strona może zawierać tekst przetłumaczony maszynowo.

Porównaj podobne pozycje

Wyświetl pełne porównanie

Pokaż różnice

1 of 1

Ta pozycja
16-66116-66317-10085
storage temp.

2-8°C

storage temp.

2-8°C

storage temp.

2-8°C

storage temp.

-

shipped in

wet ice

shipped in

wet ice

shipped in

wet ice

shipped in

dry ice

Quality Level

100

Quality Level

100

Quality Level

100

Quality Level

100

packaging

pkg of 1 mL

packaging

pkg of 1 mL

packaging

pkg of 1 mL

packaging

-

particle size

~3 μm

particle size

~3 μm

particle size

~3 μm

particle size

-

manufacturer/tradename

Magna ChIP®

manufacturer/tradename

Magna ChIP®

manufacturer/tradename

Magna ChIP®

manufacturer/tradename

Magna ChIP®


Klasa składowania

12 - Non Combustible Liquids

wgk

WGK 2

flash_point_f

Not applicable

flash_point_c

Not applicable



Certyfikaty analizy (CoA)

Poszukaj Certyfikaty analizy (CoA), wpisując numer partii/serii produktów. Numery serii i partii można znaleźć na etykiecie produktu po słowach „seria” lub „partia”.

Masz już ten produkt?

Dokumenty związane z niedawno zakupionymi produktami zostały zamieszczone w Bibliotece dokumentów.

Odwiedź Bibliotekę dokumentów


Powiązane treści

Chromatin-immunoprecipitation (ChIP) followed by next generation sequencing (ChIP-seq) of the immunoprecipitated DNA is a powerful tool for the investigation of protein:DNA interactions. To perform ChIP-seq, chromatin is isolated from cells or tissues (with or without chemical crosslinking) and fragmented. Antibodies recognizing chromatinassociated proteins of interest are used to enrich the sample for specific chromatin fragments. The DNA is recovered, sequenced on various NGS platforms, and aligned to a reference genome to determine specific protein binding loci. ChIP-seq studies have increased our knowledge of transcription factor biology, DNA methylation and histone modifications.

Cancer is a complex disease manifestation. At its core, it remains a disease of abnormal cellular proliferation and inappropriate gene expression. In the early days, carcinogenesis was viewed simply as resulting from a collection of genetic mutations that altered the gene expression of key oncogenic genes or tumor suppressor genes leading to uncontrolled growth and disease (Virani, S et al 2012). Today, however, research is showing that carcinogenesis results from the successive accumulation of heritable genetic and epigenetic changes. Moreover, the success in how we predict, treat and overcome cancer will likely involve not only understanding the consequences of direct genetic changes that can cause cancer, but also how the epigenetic and environmental changes cause cancer (Johnson C et al 2015; Waldmann T et al 2013). Epigenetics is the study of heritable gene expression as it relates to changes in DNA structure that are not tied to changes in DNA sequence but, instead, are tied to how the nucleic acid material is read or processed via the myriad of protein-protein, protein-nucleic acid, and nucleic acid-nucleic acid interactions that ultimately manifest themselves into a specific expression phenotype (Ngai SC et al 2012, Johnson C et al 2015). This review will discuss some of the principal aspects of epigenetic research and how they relate to our current understanding of carcinogenesis. Because epigenetics affects phenotype and changes in epigenetics are thought to be key to environmental adaptability and thus may in fact be reversed or manipulated, understanding the integration of experimental and epidemiologic science surrounding cancer and its many manifestations should lead to more effective cancer prognostics as well as treatments (Virani S et al 2012).

"Epigenetics describes heritable changes in gene expression caused by non-genetic mechanisms instead of by alterations in DNA sequence. These changes can be cell- or tissue-specific, and can be passed on to multiple generations. Epigenetic regulation enriches DNAbased information, allowing a cell to vary its response across diverse biological and environmental contexts. Although epigenetic mechanisms are primarily centered in the nucleus, these mechanisms can be induced by environmental signals such as hormones, nutrients, stress, and cellular damage, pointing to the involvement of cytoplasmic and extracellular factors in epigenetic regulation."

Wyświetl wszystkie powiązane treści




Numer pozycji handlu globalnego

SKUNUMER GTIN
16-66204053252377167
16-662X04053252377174

Questions

Reviews

Active Filters

  1. 1 Ratings-only review